News for Ardelyx, Inc. (ARDX)

Summary Ardelyx Inc (ARDX), a biopharmaceutical company dedicated to developing innovative medicines for unmet medical needs, has announced a conference call sc

Conference call scheduled for 4:30 p.m. Eastern Time WALTHAM, Mass., April 17, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. ( ARDX), a biopharmaceutical company f

Ardelyx (ARDX) to announce Q1 2025 financial results on May 1, 2025. Conference call scheduled for 4:30 p.m. Eastern Time. Webcast replay available for 30

We recently published a list of the 13 Best Biotech Penny Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Ardelyx Inc. (NASDAQ:ARDX) stands against other biotech penny stocks. Peter Marks’s departure from the FDA has left innovators concerned regarding the current state of the […]

Summary On April 10, 2025, Ardelyx Inc (ARDX), a biopharmaceutical company dedicated to developing first-in-class medicines, announced the presentation of a pos

**media[592019]**

Award established to recognize leaders in the field of chronic kidney disease advocacy WALTHAM, Mass., March 13, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. ( AR

On February 24, 2025, David Mott, a Director at Ardelyx Inc (ARDX), purchased 77,729 shares of the company, as reported in a SEC Filing. Following this transact

On February 26, 2025, Ardelyx Inc (ARDX), a biopharmaceutical company dedicated to developing innovative medicines, announced the approval of its New Drug Appli

PR NewswireSHANGHAI, Feb. 26, 2025 Bringing New Hope to Chinese Dialysis Patients with HyperphosphatemiaSHANGHAI, Feb. 26, 2025 /PRNewswire/ -- Shanghai Fo

Bringing New Hope to Chinese Dialysis Patients with Hyperphosphatemia

Ardelyx Inc (ARDX), a biopharmaceutical company dedicated to developing innovative medicines for unmet medical needs, announced on February 25, 2025, its partic

WALTHAM, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. ( ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercia

**media[550243]**

Call End:Ardelyx, Inc. (NASDAQ:ARDX)Q4 2024 Earnings Conference CallFebruary 20, 2025 8:00 A.M.

Stocks tumbled Thursday, with all major indices in the red, one day after the S&P 500 notched another all-time high in Wednesday’s trading session.

Although the revenue and EPS for Ardelyx (ARDX) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Ardelyx (ARDX) delivered earnings and revenue surprises of 0% and 4.45%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

**media[545476]**